
Oncology NEWS International
- Oncology NEWS International Vol 17 No 4
- Volume 17
- Issue 4
Monica Morrow joins Memorial Sloan-Kettering Cancer Center
Monica Morrow, MD, has joined the staff of Memorial Sloan-Kettering Cancer Center as chief of the Breast Service in the Department of Surgery. Dr. Morrow is also the incumbent of the Anne Burnett Windfohr Chair of Clinical Oncology, effective January 2009.
NEW YORK-Monica Morrow, MD, has joined the staff of Memorial Sloan-Kettering Cancer Center as chief of the Breast Service in the Department of Surgery. Dr. Morrow is also the incumbent of the Anne Burnett Windfohr Chair of Clinical Oncology, effective January 2009.
“We are very fortunate that Dr. Morrow, one of the country’s preeminent breast cancer surgeons, has joined our staff,” said Peter Scardino, MD, chair of the Department of Surgery. “Dr. Morrow is a superb physician, a distinguished spokesperson for breast cancer, and brings years of experience in surgical oncology to her new role.”
For more than 20 years, Dr. Morrow has been a leader in the treatment and prevention of breast cancer. After completing her surgical oncology training at MSKCC, she led the University of Chicago Hospital and Northwestern Memorial Hospital’s clinical breast programs. She served as co-principal investigator of Northwestern University’s Specialized Program of Research Excellence in Breast Cancer and, in 1996, received one of three inaugural grants from the Department of Defense Center for Excellence to increase access to modern multidisciplinary breast cancer care.
Prior to her appointment at MSKCC, she was chairman of surgical oncology at Fox Chase Cancer Center where she held the G. Willing “Wing” Pepper Chair in Cancer Research.
Articles in this issue
almost 18 years ago
Proton therapy training offeredalmost 18 years ago
Editor of Blood reviews a very bloody moviealmost 18 years ago
Artists take note: Oncology on Canvas accepting entriesalmost 18 years ago
PET affects treatment in over one-third of cancer casesalmost 18 years ago
Expanded use of Axxent approvedalmost 18 years ago
Gardasil supplemental application gets priority review designationalmost 18 years ago
Optical tomo/US monitors adjuvant chemo responsealmost 18 years ago
GIST patients resistant to imatinib/sunitinib respond to sorafenibalmost 18 years ago
Sunitinib plus a taxane active in advanced breast canceralmost 18 years ago
Stanford V yields excellent outcomes in bulky, advanced HLNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
































































































